Wound Care Overview
On the surface the wound care market looks to be buoyant. The demographic trends around ageing populations and increased incidents of diabetes and obesity suggest that the market size should be growing at a significant rate. When this is combined with the increases in political focus on the costs and impact of chronic wounds it is easy to understand why life science leaders and investors have been eager to explore the potential opportunities within the market.
Those operating within wound care will know that the reality is very different. Spend budgets have not grown at the same rate as wound prevalence, and the resources that clinical decision makers have available per patient or wound seems to decline year on year. As well as this, the largest revenue product categories have been flooded with generic entrants, with price pressure and a desire to maintain value-add services rapidly eroding margins to unsustainable levels.
The challenges around customer engagement are also evolving. Sales processes have become more fragmented and convoluted, whilst accessing decision makers is increasingly hindered by bureaucracy and gatekeepers. The digitalisation of communication has provided the opportunity to adapt marketing activities without losing impact, however the growth and protection of revenues is still primarily driven by the effectiveness of the sales activity.
This is where Taruna Medical can help. By operating a platform where the cost is directly related to revenues Taruna can reduce the fixed costs of manufacturers whilst still facilitating access to key decision makers. The Taruna members only earn a percentage of what they sell, meaning they are eager and driven to generate revenue. If you are operating within the wound care or pressure area care market and would benefit from increased engagement without increased fixed cost, then please get in touch.